Molly Rebecca Kirkconnell, Family Medicine Medicare: Medicare Enrolled Practice Location: 3802 Main Street, Occidental, CA 95465 Phone: 707-874-2444 Fax: 707-874-2003 |
Dr. Victoria Davis, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3802 Main Street, Occidental, CA 95465 Phone: 707-874-2444 Fax: 707-874-1664 |
Dr. Trina Bowen, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3802 Main Street, Occidental, CA 95465 Phone: 707-874-2444 Fax: 707-874-1664 |
Dr. Uyen T Ly, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3802 Main Street, Occidental, CA 95465 Phone: 707-874-2444 Fax: 707-874-1664 |
News Archive
This September, patients around the world will unite to share their personal stories and struggles with interstitial cystitis / bladder pain syndrome (IC/BPS). The 2013 theme, "Millions Suffer, Few Understand" encourages patients and providers to talk openly about this common yet often misunderstood pelvic pain condition.
The federal government on Monday granted Texas a waiver that could mean billions more in Medicaid dollars to hospitals over the next few years in return for having them work together to provide better care for the poor. ... State lawmakers cut deeply into the Medicaid budget this year, in part by requiring all Texas Medicaid patients to be enrolled in private health maintenance organizations for their doctor care. In recent years, patients in most urban areas were covered by HMOs, while patients in many rural counties and the Rio Grande Valley had their doctor bills paid directly by Medicaid.
TeleCommunication Systems, a world leader in secure and highly reliable wireless communication technology, today announced that The Iowa Clinic, the largest physician-owned, multi-specialty group in Central Iowa, has selected TCS' VirtuMedix platform to provide secure, HIPAA-compliant telemedicine services to its family medicine patients.
Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has enrolled the first patient into its pivotal clinical trial with its new breakthrough compound of inhaled alpha-1 antitrypsin (AAT) delivered by an Investigational eFlow Nebulizer System (PARI Pharma GmbH), in patients with alpha-1 antitrypsin deficiency.
› Verified 2 days ago